Nutex Health (NUTX) Expected to Announce Quarterly Earnings on Thursday

Nutex Health (NASDAQ:NUTX) is expected to be announcing its Q2 2025 earnings results after the market closes on Thursday, August 14th. Analysts expect the company to announce earnings of ($5.43) per share and revenue of $176.48 million for the quarter.

Nutex Health (NASDAQ:NUTX) last issued its quarterly earnings results on Tuesday, May 13th. The company reported $2.56 EPS for the quarter, topping analysts’ consensus estimates of ($0.15) by $2.71. The firm had revenue of $211.79 million for the quarter, compared to analyst estimates of $81.09 million. Nutex Health had a net margin of 10.76% and a return on equity of 42.08%.

Nutex Health Price Performance

Shares of NASDAQ:NUTX opened at $96.12 on Wednesday. The company’s fifty day moving average price is $110.57 and its 200-day moving average price is $99.40. The firm has a market capitalization of $534.43 million, a price-to-earnings ratio of 8.08 and a beta of 0.05. Nutex Health has a one year low of $11.82 and a one year high of $184.27. The company has a debt-to-equity ratio of 1.02, a current ratio of 2.27 and a quick ratio of 2.26.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on NUTX shares. Maxim Group increased their price target on shares of Nutex Health from $100.00 to $225.00 and gave the stock a “buy” rating in a report on Tuesday, May 20th. Wall Street Zen cut shares of Nutex Health from a “strong-buy” rating to a “buy” rating in a research note on Thursday, May 22nd. Finally, Benchmark upped their price objective on shares of Nutex Health from $150.00 to $300.00 and gave the company a “buy” rating in a research note on Thursday, May 15th.

Institutional Investors Weigh In On Nutex Health

A number of institutional investors have recently made changes to their positions in NUTX. Bank of America Corp DE boosted its stake in shares of Nutex Health by 6,590.3% in the 4th quarter. Bank of America Corp DE now owns 2,074 shares of the company’s stock valued at $66,000 after purchasing an additional 2,043 shares in the last quarter. Goldman Sachs Group Inc. boosted its stake in shares of Nutex Health by 17.9% in the 1st quarter. Goldman Sachs Group Inc. now owns 18,119 shares of the company’s stock valued at $852,000 after purchasing an additional 2,748 shares in the last quarter. Jane Street Group LLC purchased a new stake in shares of Nutex Health in the 1st quarter valued at $522,000. JPMorgan Chase & Co. boosted its stake in shares of Nutex Health by 41,430.0% in the 2nd quarter. JPMorgan Chase & Co. now owns 8,306 shares of the company’s stock valued at $1,034,000 after purchasing an additional 8,286 shares in the last quarter. Finally, Legal & General Group Plc purchased a new stake in shares of Nutex Health in the 2nd quarter valued at $454,000. Hedge funds and other institutional investors own 5.32% of the company’s stock.

About Nutex Health

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.